As the race to develop a safe and effective vaccine for COVID-19 continues, it may be difficult to understand the terminology used in news reports about the immune system and its response to viruses and vaccines. We’ve summarized some relevant information to help keep you updated on the latest COVID-19 vaccine research.
During the current pandemic, it may be difficult to keep pace with the rapid developments in tests, treatments and vaccines being studied for potential widespread use as approved technologies and therapies. You might read these news reports and wonder what is a “Phase 3 clinical trial” or an “emergency use authorization,” and why are these stages of approval by the U.S. Food and Drug Administration (FDA) important? Read on for explanations of common regulatory terms and phrases to help you understand medical research news.
Researchers at Sutter lead a national study to test whether a simple, home-based approach may prevent fractures for those with Parkinson’s disease.
Sutter participates in international HIV prevention study of cabotegravir, bringing new science to advance care at East Bay Advanced Care.
Testing is conducted to diagnose, understand and help prevent the spread of SARS-CoV-2/novel coronavirus. Follow our Educational Series on testing to stay abreast of the latest updates at Sutter. In Part 2 of this series, we describe antibody tests for SARS-CoV-2.
As the novel coronavirus pandemic ushers in uncertainty that may evoke anxiety, depression or other mental health concerns for today’s youth, what would a new vision for their mental health look like? New screening tools for early detection of severe depression and suicide risk, as well as a novel program called Youth Mental Health Reimagined may be part of the path forward.
Follow our Educational Series on testing to learn about polymerase chain reaction (PCR) and serology testing, and stay abreast of the latest updates at Sutter. In Part 1 of this series, we describe SARS-CoV-2 testing with PCR.
When a global health crisis began endangering communities across Northern California, Sutter research and operational staff started brainstorming new ways to track the spread of COVID-19 and launch strategies for early detection and ongoing surveillance. Learn how these data detectives are partnering to bring top-quality care to patients and communities across Sutter’s integrated network.